India
· Delayed Price · Currency is INR JHS Statistics
Total Valuation
JHS Svendgaard Laboratories has a market cap or net worth of INR 2.34 billion. The enterprise value is 2.30 billion.
| Market Cap | 2.34B |
| Enterprise Value | 2.30B |
Important Dates
The next estimated earnings date is Monday, November 4, 2024.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
JHS Svendgaard Laboratories has 85.60 million shares outstanding. The number of shares has increased by 16.71% in one year.
| Shares Outstanding | 85.60M |
| Shares Change (YoY) | +16.71% |
| Shares Change (QoQ) | +4.59% |
| Owned by Insiders (%) | 42.80% |
| Owned by Institutions (%) | 7.47% |
| Float | 46.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.55 |
| PB Ratio | 1.21 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -109.53 |
| EV / Sales | 2.75 |
| EV / EBITDA | 33.53 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.92 |
| Debt / FCF | n/a |
| Interest Coverage | 0.85 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 0.13% |
| Revenue Per Employee | 3.34M |
| Profits Per Employee | -83,928 |
| Employee Count | 250 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.47% in the last 52 weeks. The beta is 0.74, so JHS Svendgaard Laboratories's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +16.47% |
| 50-Day Moving Average | 27.75 |
| 200-Day Moving Average | 23.72 |
| Relative Strength Index (RSI) | 47.28 |
| Average Volume (20 Days) | 240,106 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, JHS Svendgaard Laboratories had revenue of INR 836.07 million and -20.98 million in losses. Loss per share was -0.27.
| Revenue | 836.07M |
| Gross Profit | 362.51M |
| Operating Income | 3.84M |
| Pretax Income | -656,000 |
| Net Income | -20.98M |
| EBITDA | 68.55M |
| EBIT | 3.84M |
| Loss Per Share | -0.27 |
Balance Sheet
The company has 103.65 million in cash and 63.18 million in debt, giving a net cash position of 40.47 million or 0.47 per share.
| Cash & Cash Equivalents | 103.65M |
| Total Debt | 63.18M |
| Net Cash | 40.47M |
| Net Cash Per Share | 0.47 |
| Equity (Book Value) | 1.70B |
| Book Value Per Share | 22.59 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 43.36%, with operating and profit margins of 0.46% and -2.51%.
| Gross Margin | 43.36% |
| Operating Margin | 0.46% |
| Pretax Margin | -0.08% |
| Profit Margin | -2.51% |
| EBITDA Margin | 8.20% |
| EBIT Margin | 0.46% |
| FCF Margin | n/a |
Dividends & Yields
JHS Svendgaard Laboratories does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -16.71% |
| Shareholder Yield | -16.71% |
| Earnings Yield | -0.98% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |